Audio Presentations (pdf) AttachmentSize MDS Genomics: Current Data and Interpretation2.92 MB Aplastic Anemia Genomics: Current Data and Interpretation, Part 11.47 MB Aplastic Anemia Genomics: Current Data and Interpretation, Part 2672.67 KB Mouse Models of Genomic Lesions: Utility as Therapeutic Platforms2.7 MB Aging and Hematopoiesis3.5 MB MDS, Aging and Inflammation2.38 MB Diagnosis of Marrow Failure Syndromes in the Genomic Era496.99 KB Telomere Modulation in Vivo3.51 MB Immunodeficiency and Marrow Failure3.84 MB Familial Myloid Diseases1.68 MB Clonal Hematopoiesis of Indeterminate Potential and MDS1.46 MB TGF-beta Signaling and the Activity of ACE-011/536 in MDS1.53 MB Role of MicroRNA Haploinsufficiency in Bone Marrow Failure1.6 MB Role and Mechanism of IFNgamma-mediated Alterations in Hematopoiesis3.4 MB Significance of Somatic Mutations in Bone Marrow Failure Syndromes557.23 KB Hematologic and Immune Defects Associated with GATA2 Mutations3.8 MB Aplastic Anemia in the Philippines650.33 KB Allogeneic Transplantation for Older Patients with Severe Aplastic Anemia1.52 MB MUD HSCT as FIrst Line Treatment in Idiopathic Severe Aplastic Anemia1.11 MB Haplo-identical Transplantation for Fanconi Anemia1.11 MB Long Term Outcomes After Allogeneic Transplantation for Fanconi Anemia1.32 MB Eltronbopag Added to Immunosuppression414.69 KB An Update on RACE: the European Trial Combining Eltrombopag and Immunosuppression 1.64 MB Eltrombopag for Aplastic Anemia in Developing Countries: The Brazilian Experience1.31 MB Where Do TPO Agonists Fit in MDS?1.05 MB Molecular Genetic Testing to Predict Response to Therapy in MDS3.16 MB Advances in Therapy of Non-del5q Lower Risk MDS284.94 KB